Global Large Volume Parenteral (LVP) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Large Volume Parenteral (LVP) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

According to our (Global Info Research) latest study, the global Large Volume Parenteral (LVP) market size was valued at US$ 11320 million in 2023 and is forecast to a readjusted size of USD 14850 million by 2030 with a CAGR of 4.0% during review period.

The main Large Volume Parenteral (LVP) players include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, etc. The top five Large Volume Parenteral (LVP) players account for approximately 66% of the total global market. Asia-Pacific is the largest consumer market for Large Volume Parenteral (LVP) accounting for about 47%, followed by Europe and North America. In terms of Type, Soft Bag LVP is the largest segment, with a share about 56%. And in terms of Application, the largest application is Therapeutic Infusion, followed by Basic Infusion.

This report is a detailed and comprehensive analysis for global Large Volume Parenteral (LVP) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Large Volume Parenteral (LVP) market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2019-2030

Global Large Volume Parenteral (LVP) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2019-2030

Global Large Volume Parenteral (LVP) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2019-2030

Global Large Volume Parenteral (LVP) market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Units), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Large Volume Parenteral (LVP)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Large Volume Parenteral (LVP) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Large Volume Parenteral (LVP) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP

Market segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion

Major players covered
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Large Volume Parenteral (LVP) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Large Volume Parenteral (LVP), with price, sales quantity, revenue, and global market share of Large Volume Parenteral (LVP) from 2019 to 2024.

Chapter 3, the Large Volume Parenteral (LVP) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Large Volume Parenteral (LVP) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Large Volume Parenteral (LVP) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Large Volume Parenteral (LVP).

Chapter 14 and 15, to describe Large Volume Parenteral (LVP) sales channel, distributors, customers, research findings and conclusion.